Research Article

Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of HbA1c in Chinese Type 2 Diabetes

Table 5

Association between quartiles of TIR and CAN.

βS.E.WaldOR (95% CI)

Model 1
 TIR Q11 (reference)
 TIR Q2-0.6860.3673.4830.0620.504 (0.245-1.035)
 TIR Q3-1.2650.39310.3470.0010.282 (0.131-0.610)
 TIR Q4-2.3640.51121.394<0.0010.094 (0.035-0.256)
Model 2
 TIR Q11 (reference)
 TIR Q2-0.6760.3713.3320.0680.508 (0.246-1.051)
 TIR Q3-1.2500.4039.6370.0020.287 (0.130-0.631)
 TIR Q4-2.3370.53219.307<0.0010.097 (0.034-0.274)
 SD0.0180.0990.0330.8561.018 (0.838-1.237)
Model 3
 TIR Q11 (reference)
 TIR Q2-0.6490.3703.0840.0790.523 (0.253-1.078)
 TIR Q3-1.2290.3959.6630.0020.292 (0.135-0.635)
 TIR Q4-2.3120.51420.241<0.0010.099 (0.036-0.271)
 MAGE0.0710.1100.4190.5171.074 (0.866-1.331)
Model 4
 TIR Q11 (reference)
 TIR Q2-0.6750.3693.3570.0670.509 (0.247-1.048)
 TIR Q3-1.2540.39410.1200.0010.285 (0.132-0.618)
 TIR Q4-2.3870.51421.538<0.0010.092 (0.034-0.252)
 CV-0.6461.4710.1930.6610.524 (0.029-9.372)
Model 5
 TIR Q11 (reference)
 TIR Q2-0.7010.3703.5980.0580.496 (0.240-1.024)
 TIR Q3-1.3030.40510.3580.0010.272 (0.123-0.601)
 TIR Q4-2.4250.53420.615<0.0010.088 (0.031-0.252)
 LAGE-0.0090.0220.1620.6880.991 (0.948-1.036)
Model 6
 TIR Q11 (reference)
 TIR Q2-0.7200.4043.1690.0750.487 (0.221-1.075)
 TIR Q3-1.3190.4747.7500.0050.267 (0.106-0.677)
 TIR Q4-2.4390.63114.916<0.0010.087 (0.025-0.301)
 ADDR-0.0030.0140.0410.8390.997 (0.971-1.025)
Model 7
 TIR Q11 (reference)
 TIR Q2-0.4170.4260.9570.3280.659 (0.286-1.519)
 TIR Q3-0.9170.4873.5410.0600.400 (0.154-1.039)
 TIR Q4-1.9580.60210.5830.0010.141 (0.043-0.459)
value0.0150.0131.3060.2531.015 (0.990-1.040)

aTIR: time in range; SD: standard deviation; MAGE: mean amplitude of glucose excursions; CV: coefficient of variation; LAGE: largest amplitude of plasma glucose excursions; ADDR: average daily risk range; HR: heart rate; CI: confidence interval. bModel 1 was adjusted for age, diabetes duration, sex, blood pressure, lipid profile, SCr, BMI, and HbA1c (%); model 2 was adjusted for variables as in model 1 and for SD; model 3 was adjusted for variables as in model 1 and for MAGE; model 4 was adjusted for variables as in model 1 and for CV; model 5 was adjusted for variables as in model 1 and for LAGE; model 6 was adjusted for variables as in model 1 and for ADDR; model 7 was adjusted for variables as in model 1 and for value. cTIR %, Q2: 41-64%, Q3: 64-83%,%.